VOR Stock: Price, Earnings History and SEC Filings
Vor Biopharma Inc. (VOR) last traded at $19.68, down 5.88% on the latest session and up 3.1% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.80 against an analyst estimate of $-0.69, a miss of 15.9%.
$19.68 -5.88%
1 month+3.14%
52-week high$26.00
52-week low$6.50
Volume759,595
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
VOR earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 11, 2026 | $-0.80 | $-0.69 | -15.94% |
| Mar 2026 | May 13, 2026 | $-0.73 | $-0.75 | +2.67% |
VOR beat the analyst EPS estimate in 1 of its last 2 reported quarters. Source: Nasdaq.
Latest SEC filings for VOR
SEC filing data is not available right now. You can search for VOR on SEC EDGAR.
VOR news
- Vor Bio Reports Third Quarter 2026 Financial Results and Provides Corporate UpdateOct 30, 2026 · finance.yahoo.com
- Telitacicept Demonstrates Durable Preservation of Kidney Function Through Two Years in Phase 3 TELIGAN Trial in IgA NephropathyOct 22, 2026 · finance.yahoo.com
About Vor Biopharma Inc.
Vor Biopharma Inc. (VOR) is a US-listed public company on Nasdaq.